List of Excipients in API ranitidine hcl tablets 150mg
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing ranitidine hcl tablets 150mg
Detailed excipient profiles for ranitidine hcl tablets 150mg
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ranitidine hcl tablets 150mg drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-375 |
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-397 |
| Allegiant Health | ranitidine hcl tablets 150mg | 69168-397 |
| >Company | >Ingredient | >NDC |
ranitidine hcl tablets 150mg drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
ranitidine hcl tablets 150mg drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-397 |
| Allegiant Health | ranitidine hcl tablets 150mg | 69168-397 |
| >Company | >Ingredient | >NDC |
ranitidine hcl tablets 150mg drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-375 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
ranitidine hcl tablets 150mg drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-375 |
| >Company | >Ingredient | >NDC |
ranitidine hcl tablets 150mg drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-397 |
| Allegiant Health | ranitidine hcl tablets 150mg | 69168-397 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
ranitidine hcl tablets 150mg drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-375 |
| >Company | >Ingredient | >NDC |
ranitidine hcl tablets 150mg drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-397 |
| Allegiant Health | ranitidine hcl tablets 150mg | 69168-397 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
ranitidine hcl tablets 150mg drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-375 |
| >Company | >Ingredient | >NDC |
ranitidine hcl tablets 150mg drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-397 |
| Allegiant Health | ranitidine hcl tablets 150mg | 69168-397 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
ranitidine hcl tablets 150mg drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-375 |
| >Company | >Ingredient | >NDC |
ranitidine hcl tablets 150mg drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-397 |
| Allegiant Health | ranitidine hcl tablets 150mg | 69168-397 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ranitidine hcl tablets 150mg drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-375 |
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-397 |
| Allegiant Health | ranitidine hcl tablets 150mg | 69168-397 |
| >Company | >Ingredient | >NDC |
ranitidine hcl tablets 150mg drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
ranitidine hcl tablets 150mg drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-375 |
| >Company | >Ingredient | >NDC |
ranitidine hcl tablets 150mg drug variants not containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-397 |
| Allegiant Health | ranitidine hcl tablets 150mg | 69168-397 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 1000
ranitidine hcl tablets 150mg drug variants containing POLYETHYLENE GLYCOL 1000
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-397 |
| Allegiant Health | ranitidine hcl tablets 150mg | 69168-397 |
| >Company | >Ingredient | >NDC |
ranitidine hcl tablets 150mg drug variants not containing POLYETHYLENE GLYCOL 1000
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-375 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
ranitidine hcl tablets 150mg drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-397 |
| Allegiant Health | ranitidine hcl tablets 150mg | 69168-397 |
| >Company | >Ingredient | >NDC |
ranitidine hcl tablets 150mg drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-375 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
ranitidine hcl tablets 150mg drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-375 |
| >Company | >Ingredient | >NDC |
ranitidine hcl tablets 150mg drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-397 |
| Allegiant Health | ranitidine hcl tablets 150mg | 69168-397 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
ranitidine hcl tablets 150mg drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-375 |
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-397 |
| Allegiant Health | ranitidine hcl tablets 150mg | 69168-397 |
| >Company | >Ingredient | >NDC |
ranitidine hcl tablets 150mg drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: VANILLIN
ranitidine hcl tablets 150mg drug variants containing VANILLIN
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-375 |
| >Company | >Ingredient | >NDC |
ranitidine hcl tablets 150mg drug variants not containing VANILLIN
| Company | Ingredient | NDC |
|---|---|---|
| Marc Glassman Inc | ranitidine hcl tablets 150mg | 68998-397 |
| Allegiant Health | ranitidine hcl tablets 150mg | 69168-397 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
